72 related articles for article (PubMed ID: 7785071)
1. Is TFIIH an activator of the p53-mediated G1/S checkpoint?
Jones CJ; Wynford-Thomas D
Trends Genet; 1995 May; 11(5):165-6. PubMed ID: 7785071
[No Abstract] [Full Text] [Related]
2. Suppression of the p53- or pRB-mediated G1 checkpoint is required for E2F-induced S-phase entry.
Lomazzi M; Moroni MC; Jensen MR; Frittoli E; Helin K
Nat Genet; 2002 Jun; 31(2):190-4. PubMed ID: 11992123
[TBL] [Abstract][Full Text] [Related]
3. Functional interactions between p53 and the TFIIH complex are affected by tumour-associated mutations.
LĂ©veillard T; Andera L; Bissonnette N; Schaeffer L; Bracco L; Egly JM; Wasylyk B
EMBO J; 1996 Apr; 15(7):1615-24. PubMed ID: 8612585
[TBL] [Abstract][Full Text] [Related]
4. Dissociation of p53-mediated suppression of homologous recombination from G1/S cell cycle checkpoint control.
Willers H; McCarthy EE; Wu B; Wunsch H; Tang W; Taghian DG; Xia F; Powell SN
Oncogene; 2000 Feb; 19(5):632-9. PubMed ID: 10698508
[TBL] [Abstract][Full Text] [Related]
5. DNA-dependent protein kinase is not required for accumulation of p53 or cell cycle arrest after DNA damage.
Rathmell WK; Kaufmann WK; Hurt JC; Byrd LL; Chu G
Cancer Res; 1997 Jan; 57(1):68-74. PubMed ID: 8988043
[TBL] [Abstract][Full Text] [Related]
6. Distinct p53-mediated G1/S checkpoint responses in two NIH3T3 subclone cells following treatment with DNA-damaging agents.
Huang TS; Kuo ML; Shew JY; Chou YW; Yang WK
Oncogene; 1996 Aug; 13(3):625-32. PubMed ID: 8760304
[TBL] [Abstract][Full Text] [Related]
7. Drug-induced apoptosis is delayed and reduced in XPD lymphoblastoid cell lines: possible role of TFIIH in p53-mediated apoptotic cell death.
Robles AI; Wang XW; Harris CC
Oncogene; 1999 Aug; 18(33):4681-8. PubMed ID: 10467415
[TBL] [Abstract][Full Text] [Related]
8. Induction of a p95/Nbs1-mediated S phase checkpoint by telomere 3' overhang specific DNA.
Eller MS; Li GZ; Firoozabadi R; Puri N; Gilchrest BA
FASEB J; 2003 Feb; 17(2):152-62. PubMed ID: 12554694
[TBL] [Abstract][Full Text] [Related]
9. Wild-type p53 can induce p21 and apoptosis in neuroblastoma cells but the DNA damage-induced G1 checkpoint function is attenuated.
McKenzie PP; Guichard SM; Middlemas DS; Ashmun RA; Danks MK; Harris LC
Clin Cancer Res; 1999 Dec; 5(12):4199-207. PubMed ID: 10632361
[TBL] [Abstract][Full Text] [Related]
10. The multiple roles of transcription/repair factor TFIIH.
Svejstrup JQ; Vichi P; Egly JM
Trends Biochem Sci; 1996 Sep; 21(9):346-50. PubMed ID: 8870499
[TBL] [Abstract][Full Text] [Related]
11. Purification of the transcription/repair factor TFIIH and evaluation of its associated activities in vitro.
Marinoni JC; Rossignol M; Egly JM
Methods; 1997 Jul; 12(3):235-53. PubMed ID: 9237168
[TBL] [Abstract][Full Text] [Related]
12. Aging. Genomic priorities in aging.
Hasty P; Vijg J
Science; 2002 May; 296(5571):1250-1. PubMed ID: 11951000
[No Abstract] [Full Text] [Related]
13. TP53 is not required for the constitutive or induced repair of DNA damage produced by ionizing radiation at the G1/S-phase border.
Whisnant-Hurst N; Leadon SA
Radiat Res; 1999 Mar; 151(3):263-9. PubMed ID: 10073663
[TBL] [Abstract][Full Text] [Related]
14. Modular organization of the E2F1 activation domain and its interaction with general transcription factors TBP and TFIIH.
Pearson A; Greenblatt J
Oncogene; 1997 Nov; 15(22):2643-58. PubMed ID: 9400991
[TBL] [Abstract][Full Text] [Related]
15. Mathematical modeling and sensitivity analysis of G1/S phase in the cell cycle including the DNA-damage signal transduction pathway.
Iwamoto K; Tashima Y; Hamada H; Eguchi Y; Okamoto M
Biosystems; 2008; 94(1-2):109-17. PubMed ID: 18606207
[TBL] [Abstract][Full Text] [Related]
16. Requirements for p53 and the ATM gene product in the regulation of G1/S and S phase checkpoints.
Xie G; Habbersett RC; Jia Y; Peterson SR; Lehnert BE; Bradbury EM; D'Anna JA
Oncogene; 1998 Feb; 16(6):721-36. PubMed ID: 9488036
[TBL] [Abstract][Full Text] [Related]
17. S phase cell-cycle arrest following DNA damage is independent of the p53/p21(WAF1) signalling pathway.
Wyllie FS; Haughton MF; Bond JA; Rowson JM; Jones CJ; Wynford-Thomas D
Oncogene; 1996 Mar; 12(5):1077-82. PubMed ID: 8649799
[TBL] [Abstract][Full Text] [Related]
18. Functional interplay between p53 and E2F through co-activator p300.
Lee CW; Sørensen TS; Shikama N; La Thangue NB
Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
[TBL] [Abstract][Full Text] [Related]
19. Defects in G1-S cell cycle control in head and neck cancer: a review.
Michalides RJ; van de Brekel M; Balm F
Head Neck; 2002 Jul; 24(7):694-704. PubMed ID: 12112544
[TBL] [Abstract][Full Text] [Related]
20. Depletion of PKD1 by an antisense oligodeoxynucleotide induces premature G1/S-phase transition.
Kim H; Bae Y; Jeong W; Ahn C; Kang S
Eur J Hum Genet; 2004 Jun; 12(6):433-40. PubMed ID: 15054393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]